z-logo
Premium
Circulating Cell‐Derived Microparticles in Women with Pregnancy Loss
Author(s) -
AlijotasReig Jaume,
PalacioGarcia Carles,
FarranCodina Immaculada,
Zarzoso Cristina,
CaberoRoura Luis,
VilardellTarres Miquel
Publication year - 2011
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/j.1600-0897.2010.00972.x
Subject(s) - cd31 , andrology , flow cytometry , pregnancy , endothelial stem cell , immunology , medicine , platelet , gestation , chemistry , biology , angiogenesis , biochemistry , genetics , in vitro
Citation 
Alijotas‐Reig J, Palacio‐Garcia C, Farran‐Codina I, Zarzoso C, Cabero‐Roura L, Vilardell‐Tarres M. Circulating cell‐derived microparticles in women with pregnancy loss. Am J Reprod Immunol 2011; 66: 199–208 Problem  To analyze cell‐derived microparticles (cMP) in pregnancy loss (PL), both recurrent miscarriages (RM) and unexplained fetal loss (UFL). Method of study  Non‐matched case–control study was performed at Vall d’Hebron Hospital. Cell‐derived microparticles of 53 PL cases, 30 with RM, 16 with UFL, and 7 (RM + UFL), were compared to 38 healthy pregnant women. Twenty healthy non‐pregnant women act as controls. Cell‐derived microparticles were analyzed through flow cytometry. Results are given as total annexin (A5+), endothelial‐(CD144+/CD31+ CD41−), platelet‐(CD41+), leukocyte‐(CD45+) and CD41− c‐MP/μL of plasma. Antiphospholipid antibodies (aPLA) were analyzed according to established methods. Results  Comparing PL versus healthy pregnant, we observed a significant endothelial cMP decrease in PL. When comparing RM subgroup with controls, we observed significant decreases in endothelial cMP. When comparing the PL positive for aPLA versus PL‐aPLA‐negative, no cMP numbering differences were seen. Conclusion  Pregnancy loss seems to be related to endothelial cell activation and/or consumption. A relationship between aPLA and cMP could not be demonstrated.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here